脂肪性肝炎
脂肪组织
肝硬化
再生医学
干细胞
医学
病理
细胞生物学
内科学
生物
脂肪肝
疾病
作者
Akihiro Seki,Yoshio Sakai,Takuya Komura,Alessandro Nasti,Keiko Yoshida,Mami Higashimoto,Masao Honda,Soichiro Usui,Masayuki Takamura,Toshinari Takamura,Takahiro Ochiya,Kengo Furuichi,Takashi Wada,Shuichi Kaneko
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2013-05-17
卷期号:58 (3): 1133-1142
被引量:122
摘要
UNLABELLED: Cirrhosis is a chronic liver disease that impairs hepatic function and causes advanced fibrosis. Mesenchymal stem cells have gained recent popularity as a regenerative therapy since they possess immunomodulatory functions. We found that injected adipose tissue-derived stem cells (ADSCs) reside in the liver. Injection of ADSCs also restores albumin expression in hepatic parenchymal cells and ameliorates fibrosis in a nonalcoholic steatohepatitis model of cirrhosis in mice. Gene expression analysis of the liver identifies up- and down-regulation of genes, indicating regeneration/repair and anti-inflammatory processes following ADSC injection. ADSC treatment also decreases the number of intrahepatic infiltrating CD11b(+) and Gr-1(+) cells and reduces the ratio of CD8(+) /CD4(+) cells in hepatic inflammatory cells. This is consistent with down-regulation of genes in hepatic inflammatory cells related to antigen presentation and helper T-cell activation. CONCLUSION: These results suggest that ADSC therapy is beneficial in cirrhosis, as it can repair and restore the function of the impaired liver.
科研通智能强力驱动
Strongly Powered by AbleSci AI